Xvivo Perfusion AB (XVIVO) — Capital Reinvestment Ratio
Xvivo Perfusion AB (XVIVO) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr86.93 Million) in capital expenditures (Skr86.93 Million). See Xvivo Perfusion AB balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xvivo Perfusion AB Capital Reinvestment Ratio (2011–2025)
This chart tracks Xvivo Perfusion AB's Capital Reinvestment Ratio across 12 annual periods. Check XVIVO total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xvivo Perfusion AB (2011–2025)
Year-by-year Capital Reinvestment Ratio for Xvivo Perfusion AB from 2011 to 2025. For live market cap and broader valuation context, see Xvivo Perfusion AB (XVIVO) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr101.07 Million | Skr101.07 Million | ▼ -42.4% |
| 2024 | 1.74x | Skr111.29 Million | Skr193.15 Million | ▲ +86.8% |
| 2023 | 0.93x | Skr46.29 Million | Skr43.02 Million | ▼ -80.2% |
| 2022 | 4.70x | Skr27.86 Million | Skr130.95 Million | ▲ +65.7% |
| 2019 | 2.84x | Skr29.50 Million | Skr83.69 Million | ▲ +22.5% |
| 2018 | 2.32x | Skr23.63 Million | Skr54.71 Million | ▲ +47.1% |
| 2017 | 1.57x | Skr22.19 Million | Skr34.93 Million | ▼ -3.7% |
| 2016 | 1.63x | Skr12.55 Million | Skr20.51 Million | ▲ +6.1% |
| 2015 | 1.54x | Skr8.58 Million | Skr13.21 Million | ▲ +64.7% |
| 2013 | 0.94x | Skr13.46 Million | Skr12.59 Million | ▼ -47.3% |
| 2012 | 1.77x | Skr1.67 Million | Skr2.96 Million | ▲ +96549.9% |
| 2011 | 0.00x | Skr14.17 Million | Skr26.00K | — |